Stockscreener 앱 받기
53.43
0.75%
0.40
시장 영업 전:
53.86
0.43
+0.80%
전일 마감가:
$53.03
열려 있는:
$52.44
하루 거래량:
1.78M
Relative Volume:
1.82
시가총액:
$2.95B
수익:
$199.84M
순이익/손실:
$-100.06M
주가수익비율:
-27.40
EPS:
-1.95
순현금흐름:
$-103.57M
1주 성능:
-0.61%
1개월 성능:
-8.04%
6개월 성능:
-21.66%
1년 성능:
+6.46%
1일 변동 폭
$52.20
$53.60
1주일 범위
$51.27
$54.74
52주 변동 폭
$47.04
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
PRCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
53.43 | 2.95B | 199.84M | -100.06M | -103.57M | -1.95 |
|
ABT
Abbott Laboratories
|
129.89 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
93.58 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
339.59 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
81.80 | 104.24B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
69.20 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Wells Fargo & Company MN - Defense World
Piper Sandler maintains $100 target on Procept BioRobotics stock By Investing.com - Investing.com Canada
Piper Sandler maintains $100 target on Procept BioRobotics stock - Investing.com Australia
Analysts Set PROCEPT BioRobotics Co. (NASDAQ:PRCT) PT at $91.43 - Defense World
Truist Financial Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $70.00 - Defense World
Leading Urologists Join PROCEPT BioRobotics Leadership for Exclusive Investor Insights - Stock Titan
Commonwealth Equity Services LLC Buys New Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
JPMorgan Chase & Co. Lowers Stock Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Vanguard Group Inc. Purchases 297,075 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Corebridge Financial Inc. Sells 496 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Raymond James Financial Inc. Purchases Shares of 20,453 PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
HighTower Advisors LLC Buys 1,026 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Sei Investments Co. Grows Stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Teacher Retirement System of Texas Takes Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires - Insider Monkey
10 Best Robotics Stocks to Buy According to Billionaires - Insider Monkey
Aquablation therapy shows promise in prostate treatment By Investing.com - Investing.com Australia
Aquablation therapy shows promise in prostate treatment - Investing.com India
PROCEPT BioRobotics Announces Positive Results for Aquablation Therapy in WATER III Trial Presented at EAU 2025 Annual Congress - Nasdaq
New Clinical Data: Aquablation Reduces Sexual Side Effects by 80% vs Traditional Prostate Treatment - Stock Titan
PNC Financial Services Group Inc. Sells 1,582 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Swiss National Bank Has $7.82 Million Stock Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives $94.29 Consensus Target Price from Analysts - Defense World
PROCEPT BioRobotics Corp (PRCT) Trading 0.12% Higher on Mar 21 - GuruFocus.com
Procept Biorobotics CEO Zadno Reza sells $312,403 in stock By Investing.com - Investing.com India
Top Executives at PROCEPT BioRobotics Unload Significant Shares! - TipRanks
Procept BioRobotics CFO Kevin Waters sells shares worth $41,824 By Investing.com - Investing.com Canada
Procept BioRobotics EVP Alaleh sells $18,030 in stock By Investing.com - Investing.com Australia
Procept BioRobotics EVP Alaleh sells $18,030 in stock - Investing.com
Procept Biorobotics EVP sells $14,093 in common stock - Investing.com
Procept Biorobotics CEO Zadno Reza sells $312,403 in stock - Investing.com
Procept BioRobotics CFO Kevin Waters sells shares worth $41,824 - Investing.com
PROCEPT BioRobotics Corp Executives Sell Shares to Cover Tax Obligations - TradingView
Procept Biorobotics EVP sells $14,093 in common stock By Investing.com - Investing.com UK
Charles Schwab Investment Management Inc. Acquires 23,869 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
US Bancorp DE Has $109,000 Stock Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics to Host Investor Event at AUA Annual Meeting in Las Vegas on April 25, 2025 - Nasdaq
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada - Yahoo Finance
Victory Capital Management Inc. Sells 40,179 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - The AM Reporter
Procept Biorobotics at Leerink Conference: Strategic Growth and Challenges - Investing.com
Buy Rating on PROCEPT BioRobotics: Attractive Entry Point Amidst Growth Potential and Upcoming Clinical Catalysts - TipRanks
Bank of New York Mellon Corp Increases Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Procept Biorobotics EVP sells shares worth $223,229 By Investing.com - Investing.com Australia
Procept Biorobotics CFO Kevin Waters sells $224,517 in stock By Investing.com - Investing.com South Africa
Procept Biorobotics EVP sells shares worth $223,229 - Investing.com
Procept Biorobotics CFO Kevin Waters sells $224,517 in stock - Investing.com India
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.79%
자본화:
|
볼륨(24시간):